[EN] COMPOUND HAVING BET INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREFOR<br/>[FR] COMPOSÉ PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE BET, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 具有BET抑制活性的化合物及其制备方法和用途
申请人:SHANGHAI HAIHE PHARMACEUTICAL CO LTD
公开号:WO2019154329A1
公开(公告)日:2019-08-15
本发明属于药物化学领域。具体地,本发明涉及一系列具有新型结构的BET(bromodomain and extra-terminal domain)抑制剂,尤其是靶向BRD4(Bromodomain-containing protein 4)的抑制剂,及其制备方法和用途。其结构如下列通式(I)所示。这些化合物或其立体异构体、外消旋物、几何异构体、互变异构体、前药、水合物、溶剂化物、晶型或其药学上可接受的盐及药物组合物,可用于治疗或/和预防由溴结构域蛋白介导的相关疾病。
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding
作者:Fredric J. Vinick、Nicholas A. Saccomano、B. Kenneth Koe、Jann A. Nielsen、Ian H. Williams、Peter F. Thadeio、Stanley Jung、Morgan Meltz、Jonathan Johnson、Lorraine A. Lebel、Lorena L. Russo、David Helweg
DOI:10.1021/jm00105a015
日期:1991.1
The synthesis and biological properties of a series of nicotinamide ethers are described. These compounds, structurally novel calcium-independent phosphodiesterase inhibitors, also inhibit the binding of [H-3]rolipram to rat brain membranes and reverse reserpine-induced hypothermia in the mouse. Several compounds exhibited potent in vivo activity comparable to the standard agent, rolipram.
VINICK, FREDRIC J.;SACCOMANO, NICHOLAS A.;KOE, B. KENNETH;NIELSEN, JANN A+, J. MED. CHEM., 34,(1991) N, C. 86-89
作者:VINICK, FREDRIC J.、SACCOMANO, NICHOLAS A.、KOE, B. KENNETH、NIELSEN, JANN A+